Home/Pipeline/Inspire 4.0 / Next-Gen System

Inspire 4.0 / Next-Gen System

Obstructive Sleep Apnea (OSA)

DevelopmentActive

Key Facts

Indication
Obstructive Sleep Apnea (OSA)
Phase
Development
Status
Active
Company

About Inspire Medical Systems

Inspire Medical Systems' mission is to address the critical unmet need in obstructive sleep apnea (OSA) treatment by providing an effective, patient-friendly alternative to CPAP. The company has achieved significant commercial success with its FDA-approved Inspire upper airway stimulation system, establishing robust clinical evidence, broad insurance coverage, and a scalable commercial infrastructure in the United States. Its strategy centers on deepening market penetration through surgeon education, expanding clinical indications, and leveraging its first-mover advantage in a high-growth neuromodulation segment of the sleep apnea market.

View full company profile

Therapeutic Areas

Other Obstructive Sleep Apnea (OSA) Drugs

DrugCompanyPhase
SCI-110SciSparcPreclinical
DeltaWave CPAP Nasal Pillow SystemRemsleepCommercial
AD109ApnimedPhase 3
Sleep Apnea Biomarker ServicesThe Siesta GroupService Offering
Injectable Neurostimulation SystemInvicta MedicalProof-of-Concept
IHL-42XIncannex HealthcarePhase 2/3